Mursla

Provider of diagnostic device for cancer detection

placeLondon, England, United Kingdom calendar_todayFounded 2017 groups9 employees language mursla.com

Registered entities

Social engagement

Social engagement: 3.5K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

28 investors on record; lead investors include Future Fund.

Investor typeCountShare
Venture capital14%
Private equity414%
Other / undisclosed2382%

Recent activity

12 May 2026
Recognition
18 Mar 2026
Event
Canaccord Genuity - Global Capital Markets Early Cancer Detection Day
4 Mar 2026
Milestone
regulatory
Coming soon